Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Fundamental Mathematical Principles in Pharmacokinetics: Rate and Order of Reaction01:15

Fundamental Mathematical Principles in Pharmacokinetics: Rate and Order of Reaction

In pharmacokinetics, the rates and order of reactions play a crucial role in understanding how the body processes drugs and help us comprehend drug absorption, distribution, metabolism, and elimination. A critical concept in pharmacokinetics is the rate constant, which quantifies the speed of a reaction. It provides valuable information about the kinetics of drug elimination. The rate constant allows us to determine the rate at which drugs are eliminated from the body.
Pharmacokinetic reactions...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Effect of high-intensity interval exercise on metformin pharmacokinetics in healthy men, assessed through a population pharmacokinetic model.

British journal of pharmacology·2025
Same author

Extrapolation of lung pharmacokinetics of bedaquiline across species using physiologically-based pharmacokinetic modelling.

British journal of clinical pharmacology·2025
Same author

Publisher Correction: Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data.

The AAPS journal·2025
Same author

Simultaneous Estimation of fm and F<sub>G</sub> Values Directly from Clinical Drug-Drug Interaction Study Data.

The AAPS journal·2025
Same author

Population pharmacokinetic model of oral minocycline in critically ill adult patients with ventilator-associated pneumonia.

The Journal of antimicrobial chemotherapy·2025

Related Experiment Video

Updated: Jun 18, 2026

An All-Human Hepatic Culture System for Drug Development Applications
07:23

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

A method for robust model order reduction in pharmacokinetics.

Aristides Dokoumetzidis1, Leon Aarons

  • 1School of Pharmacy, University of Athens, Panepistimiopolis, Athens, 157 71, Greece. adokoum@pharm.uoa.gr

Journal of Pharmacokinetics and Pharmacodynamics
|November 26, 2009
PubMed
Summary
This summary is machine-generated.

This study introduces a Bayesian automated method for simplifying large differential equation systems, accounting for parameter variability. The new approach enhances model reduction robustness by optimizing lumping schemes on average, outperforming methods ignoring parameter uncertainty.

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jun 18, 2026

An All-Human Hepatic Culture System for Drug Development Applications
07:23

An All-Human Hepatic Culture System for Drug Development Applications

Published on: October 20, 2023

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Area of Science:

  • Computational Biology
  • Pharmacokinetics and Pharmacodynamics
  • Mathematical Modeling

Background:

  • Model reduction simplifies complex systems but often lacks robustness to parameter variations.
  • Existing methods for reducing large systems of differential equations may fail when parameter values vary.

Purpose of the Study:

  • To develop a Bayesian automated method for model reduction by lumping that robustly handles parameter variability.
  • To improve the reliability of model reduction techniques in applications like Physiologically Based Pharmacokinetic (PBPK) and Systems Biology models.

Main Methods:

  • A stepwise Bayesian algorithm was developed to determine optimal lumping schemes, incorporating prior parameter distributions.
  • The method reduces system dimensionality one step at a time, with each step conditional on the previous ones.
  • Applied to a literature-based PBPK model for barbiturates with introduced parameter variability (20% CV).

Main Results:

  • The Bayesian method produced a lumping scheme that was optimal on average across the parameter distribution.
  • This outperformed a non-Bayesian method, which yielded a scheme optimal only for nominal values but poor otherwise.
  • The Bayesian approach demonstrated superior robustness and performance in the presence of parameter variability.

Conclusions:

  • The developed Bayesian automated lumping method effectively addresses the lack of robustness in model reduction due to parameter variability.
  • Lumping strategies offer a more powerful approach to model reduction compared to state elimination, which can be seen as a special case.
  • This method provides a robust tool for simplifying complex biological and pharmacokinetic models, enhancing their practical utility.